Systemic inflammation predicts all-cause mortality: a glasgow inflammation outcome study

PloS One
Michael J ProctorDavid S Morrison

Abstract

Markers of the systemic inflammatory response, including C-reactive protein and albumin (combined to form the modified Glasgow Prognostic Score), as well as neutrophil, lymphocyte and platelet counts have been shown to be prognostic of survival in patients with cancer. The aim of the present study was to examine the prognostic relationship between these markers of the systemic inflammatory response and all-cause, cancer, cardiovascular and cerebrovascular mortality in a large incidentally sampled cohort. Patients (n = 160 481) who had an incidental blood sample taken between 2000 and 2008 were studied for the prognostic value of C-reactive protein (>10mg/l, albumin (>35mg/l), neutrophil (>7.5×109/l) lymphocyte and platelet counts. Also, patients (n = 52 091) sampled following the introduction of high sensitivity C-reactive protein (>3mg/l) measurements were studied. A combination of these markers, to make cumulative inflammation-based scores, were investigated. In all patients (n = 160 481) C-reactive protein (>10mg/l) (HR 2.71, p<0.001), albumin (>35mg/l) (HR 3.68, p<0.001) and neutrophil counts (HR 2.18, p<0.001) were independently predictive of all-cause mortality. These associations were also observed in cancer, cardiovascu...Continue Reading

References

Jun 1, 1997·Journal of Clinical Epidemiology·P Goldwasser, J Feldman
Apr 3, 2001·Stroke; a Journal of Cerebral Circulation·M Di NapoliV Bocola
Dec 25, 2007·Clinical Chemistry·Claudia MarsikGeorg Endler
Aug 4, 2009·European Journal of Clinical Investigation·G GrimmB Jilma
Apr 29, 2010·European Heart Journal·Jeppe ZachoBørge G Nordestgaard
Nov 6, 2010·QJM : Monthly Journal of the Association of Physicians·A C PhillipsG D Batty
Nov 26, 2010·Circulation·Philip GreenlandUNKNOWN American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Mar 4, 2011·Journal of Epidemiology·Seounghee LeeJoohon Sung
Jul 5, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Michael J ProctorDonald C McMillan
Oct 25, 2011·Development and Psychopathology·Dario Maestripieri, Christy L Hoffman
Oct 5, 2012·The New England Journal of Medicine·UNKNOWN Emerging Risk Factors CollaborationJohn Danesh
Oct 25, 2012·BMC Public Health·Mieke Van HemelrijckSabine Rohrmann
Nov 9, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Young-Jin KoMinseon Park
Mar 26, 2013·Journal of the American Heart Association·Payman ZamaniUNKNOWN Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators
Apr 23, 2013·Critical Reviews in Oncology/hematology·Graeme J K GuthrieStephen J Clarke
Aug 8, 2013·British Journal of Cancer·D C McMillan
Nov 19, 2013·Journal of Immigrant and Minority Health·Jennifer L GayJoseph B McCormick
Feb 20, 2014·British Journal of Cancer·C S D Roxburgh, D C McMillan

❮ Previous
Next ❯

Citations

Jan 7, 2016·Frontiers in Immunology·Emidio M de Matos-NetoMarília Seelaender
Mar 23, 2017·Annals of Epidemiology·Geoffrey C KabatThomas E Rohan
Mar 31, 2017·PloS One·Xuechao LiuXiaowei Sun
Jul 28, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Lisa I BackusLarry A Mole
Jun 7, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kirsten K NessGregory T Armstrong
Jan 30, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Lisa I BackusLarry A Mole
Oct 20, 2018·Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia·Satoru KobayashiMasayuki Chida
Oct 10, 2018·Epidemiology·Humberto ParadaMelissa A Troester
Dec 7, 2019·Nature Medicine·David FurmanGeorge M Slavich
Jul 1, 2020·The Journal of Applied Laboratory Medicine·Michael E GerlingUNKNOWN APPROACH Investigators
Sep 11, 2020·Current Cardiology Reports·Elena C CastilloGuillermo Torre-Amione
Apr 26, 2019·Journal of Cardiopulmonary Rehabilitation and Prevention·Raviteja R GuddetiVenkata Mahesh Alla
Apr 26, 2019·International Journal of Clinical Oncology·Xiao-Chun NiShuang-Jian Qiu
Mar 16, 2019·Metabolic Brain Disease·Edna Maria Vissoci ReicheMichael Maes
Jul 20, 2020·Biophysics Reviews·R K SeetoB L Dale
Apr 16, 2020·Clinical Journal of the American Society of Nephrology : CJASN·Dominik SteublUNKNOWN GCKD Study Investigators
Oct 11, 2019·Psychosomatic Medicine·Carrianne J Leschak, Naomi I Eisenberger
May 27, 2020·International Journal of Sports Medicine·Roy Tzemah ShaharMaayan Agmon
Sep 19, 2020·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M StaresS Clive
Feb 12, 2021·Brain, Behavior, and Immunity·Páraic S O'SúilleabháinAngelina R Sutin
Aug 16, 2021·Brain, Behavior, and Immunity·Joshua M SchrockBrian Mustanski
Nov 7, 2020·Journal of the American Medical Directors Association·Suey S Y YeungJean Woo

❮ Previous
Next ❯

Software Mentioned

NYSIIS
SPSS

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.